Parallel Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$981 Sell
65
-200
-75% -$3.49K ﹤0.01% 3697
2026
Q1
$5.08K Buy
265
+200
+308% +$4.35K ﹤0.01% 3024
2025
Q4
$1.43K Buy
65
+42
+183% +$758 ﹤0.01% 3219
2025
Q3
$279 Sell
23
-566
-96% -$7.66K ﹤0.01% 3406
2025
Q2
$11K Sell
589
-430
-42% -$8.52K ﹤0.01% 2446
2025
Q1
$19.5K Sell
1,019
-171
-14% -$5K ﹤0.01% 2162
2024
Q4
$42.9K Sell
1,190
-26
-2% -$879 ﹤0.01% 1724
2024
Q3
$51.6K Sell
1,216
-91
-7% -$3.86K ﹤0.01% 1613
2024
Q2
$52.7K Buy
1,307
+111
+9% +$4.63K ﹤0.01% 1490
2024
Q1
$42.4K Buy
1,196
+662
+124% +$17.7K ﹤0.01% 1578
2023
Q4
$15.8K Buy
534
+472
+761% +$9.79K ﹤0.01% 2081
2023
Q3
$1.29K Buy
62
+20
+48% +$549 ﹤0.01% 2929
2023
Q2
$1.03K Sell
42
-10
-19% -$322 ﹤0.01% 2924
2023
Q1
$2.11K Sell
52
-173
-77% -$7.16K ﹤0.01% 2757
2022
Q4
$10.1K Sell
225
-102
-31% -$4.62K ﹤0.01% 2017
2022
Q3
$16K Buy
327
+99
+43% +$5.43K ﹤0.01% 1794
2022
Q2
$13K Buy
228
+159
+230% +$13.1K ﹤0.01% 1882
2022
Q1
$8K Buy
69
+56
+431% +$6.54K ﹤0.01% 2131
2021
Q4
$2K Buy
+13
New +$1.75K ﹤0.01% 2765

Other funds holding TNDM

Parallel Advisors's TNDM Position: Q2 2026 in Review

Parallel Advisors reduced its Tandem Diabetes Care (TNDM) stake by 75% in Q2 2026, selling an estimated $3.49K and leaving 65 shares worth $981. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Parallel Advisors first reported a position in TNDM in Q4 2021 and has held it in 19 quarters since. The position peaked at $52.7K in Q2 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Parallel Advisors held 65 shares of Tandem Diabetes Care worth $981 as of Q2 2026.
  • Parallel Advisors sold 200 Tandem Diabetes Care shares in Q2 2026, an estimated $3.49K.
  • Tandem Diabetes Care made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3697 holding.
  • Parallel Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 19 quarters since.
  • Parallel Advisors's Tandem Diabetes Care position peaked at $52.7K in Q2 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.